ARYA Sciences Acquisition Corp V (ARYE) 10-K12 Apr 232022 FY Annual reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Dec. 31, 2022	Apr. 12, 2023	Jun. 30, 2022
Entity Listings [Line Items]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Document Transition Report	false
Entity File Number	001-40595
Entity Registrant Name	ARYA SCIENCES ACQUISITION CORP V
Entity Central Index Key	0001852432
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1590338
Entity Address, Address Line One	51 Astor Place, 10th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10003
City Area Code	212
Local Phone Number	284-2300
Title of 12(b) Security	Class A Ordinary Share, $0.0001 par value
Trading Symbol	ARYE
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	true
Entity Public Float			$ 145,314,000
Auditor Name	WithumSmith+Brown, PC
Auditor Location	New York
Auditor Firm ID	100
Class A Ordinary Shares [Member]
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		15,449,000
Class B Ordinary Shares [Member]
Entity Listings [Line Items]
Entity Common Stock, Shares Outstanding		3,737,500

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash	$ 385,187	$ 775,885
Prepaid expenses	157,000	460,995
Total current assets	542,187	1,236,880
Investments held in Trust Account	151,601,721	149,530,514
Total Assets	152,143,908	150,767,394
Current liabilities:
Accounts payable	11,466	12,663
Accrued expenses	2,776,182	2,703,653
Due to related party	90,000	0
Total current liabilities	2,877,648	2,716,316
Deferred underwriting commissions	2,616,250	5,232,500
Total Liabilities	5,493,898	7,948,816
Commitments and Contingencies
Class A ordinary shares subject to possible redemption; 14,950,000 shares at redemption value of approximately $10.13 and $10.00 per share at December 31, 2022 and 2021, respectively	151,501,721	149,500,000
Shareholders' Deficit:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(4,852,135)	(6,681,846)
Total shareholders' deficit	(4,851,711)	(6,681,422)
Total Liabilities and Shareholders' Deficit	152,143,908	150,767,394
Class A Ordinary Shares [Member]
Shareholders' Deficit:
Common stock	50	50
Class B Ordinary Shares [Member]
Shareholders' Deficit:
Common stock	$ 374	$ 374

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Shareholders' Deficit:
Preference shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preference shares, shares authorized (in shares)	1,000,000	1,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Class A Ordinary Shares [Member]
Liabilities and Shareholders' Deficit
Ordinary shares subject to possible redemption (in shares)	14,950,000	14,950,000
Ordinary shares, redemption price per share (in dollars per share)	$ 10.13	$ 10
Shareholders' Deficit:
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	479,000,000	479,000,000
Ordinary shares, shares issued (in shares)	499,000	499,000
Ordinary shares, shares outstanding (in shares)	499,000	499,000
Class B Ordinary Shares [Member]
Shareholders' Deficit:
Ordinary shares, par value (in dollars per share)	$ 0.0001	$ 0.0001
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, shares issued (in shares)	3,737,500	3,737,500
Ordinary shares, shares outstanding (in shares)	3,737,500	3,737,500

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
STATEMENTS OF OPERATIONS - USD ($)	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2022
General and administrative expenses	$ 163,022	$ 627,680	$ 3,017,782	$ 856,025
Loss from operations	(163,022)	(627,680)	(3,017,782)	(856,025)
Other income
Interest income and unrealized gain on investments held in Trust Account	661,899	849,701	30,514	2,071,207
Total other income	661,899	849,701	30,514	2,071,207
Net income (loss)	$ 498,877	$ 222,021	$ (2,987,268)	$ 1,215,182
Class A Ordinary Shares [Member]
Other income
Weighted average ordinary shares outstanding, basic (in shares)	15,449,000	15,449,000	8,390,831	15,449,000
Weighted average ordinary shares outstanding, diluted (in shares)	15,449,000	15,449,000	8,390,831	15,449,000
Basic net income (loss) per ordinary share (in dollars par share)	$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Diluted net income (loss) per ordinary share (in dollars par share)	$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Class B Ordinary Shares [Member]
Other income
Weighted average ordinary shares outstanding, basic (in shares)	3,737,500	3,737,500	3,514,776	3,737,500
Weighted average ordinary shares outstanding, diluted (in shares)	3,737,500	3,737,500	3,514,776	3,737,500
Basic net income (loss) per ordinary share (in dollars par share)	$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Diluted net income (loss) per ordinary share (in dollars par share)	$ 0.02	$ 0.01	$ (0.25)	$ 0.06

STATEMENTS OF CHANGES IN SHAREH

STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($)	Ordinary Shares [Member] Class A [Member]	Ordinary Shares [Member] Class B [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Beginning balance at Feb. 22, 2021	$ 0	$ 0	$ 0	$ 0	$ 0
Beginning balance (in shares) at Feb. 22, 2021	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class B ordinary shares to Sponsor	$ 0	$ 374	24,626	0	25,000
Issuance of Class B ordinary shares to Sponsor (in shares)	0	3,737,500
Sale of private placement shares to Sponsor in private placement	$ 50	$ 0	4,989,950	0	4,990,000
Sale of private placement shares to Sponsor in private placement (in shares)	499,000	0
Accretion on Class A ordinary shares subject to possible redemption	$ 0	$ 0	(5,014,576)	(3,694,578)	(8,709,154)
Net income (loss)	0	0	0	(2,987,268)	(2,987,268)
Ending balance at Dec. 31, 2021	$ 50	$ 374	0	(6,681,846)	(6,681,422)
Ending balance (in shares) at Dec. 31, 2021	499,000	3,737,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase in redemption value of Class A ordinary shares subject to possible redemption			0	1,836,035	1,836,035
Net income (loss)			0	222,021	222,021
Ending balance at Sep. 30, 2022	$ 50	$ 374	0	(4,623,790)	(4,623,366)
Ending balance (in shares) at Sep. 30, 2022	499,000	3,737,500
Beginning balance at Dec. 31, 2021	$ 50	$ 374	0	(6,681,846)	(6,681,422)
Beginning balance (in shares) at Dec. 31, 2021	499,000	3,737,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase in redemption value of Class A ordinary shares subject to possible redemption	$ 0	$ 0	0	614,529	614,529
Net income (loss)	0	0	0	1,215,182	1,215,182
Ending balance at Dec. 31, 2022	$ 50	$ 374	0	(4,852,135)	(4,851,711)
Ending balance (in shares) at Dec. 31, 2022	499,000	3,737,500
Beginning balance at Jun. 30, 2022	$ 50	$ 374	0	(7,077,018)	(7,076,594)
Beginning balance (in shares) at Jun. 30, 2022	499,000	3,737,500
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase in redemption value of Class A ordinary shares subject to possible redemption			0	1,954,351	1,954,351
Net income (loss)			0	498,877	498,877
Ending balance at Sep. 30, 2022	$ 50	$ 374	$ 0	$ (4,623,790)	$ (4,623,366)
Ending balance (in shares) at Sep. 30, 2022	499,000	3,737,500

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	10 Months Ended	12 Months Ended
STATEMENTS OF CASH FLOWS - USD ($)	Dec. 31, 2021	Dec. 31, 2022
Cash Flows from Operating Activities:
Net income (loss)	$ (2,987,268)	$ 1,215,182
Adjustments to reconcile net income (loss) to net cash used in operating activities:
General and administrative expenses advanced by related party	1,379	0
Interest income and unrealized gain on investments held in Trust Account	(30,514)	(2,071,207)
Changes in operating assets and liabilities:
Prepaid expenses	(460,995)	303,995
Accounts payable	12,663	(1,197)
Accrued expenses	2,633,653	72,529
Due to related party	0	90,000
Net cash used in operating activities	(831,082)	(390,698)
Cash Flows from Investing Activities:
Cash deposited in Trust Account	(149,500,000)	0
Net cash used in investing activities	(149,500,000)	0
Cash Flows from Financing Activities:
Proceeds from note payable to related party	150,000	0
Repayment of note payable and advances to related party	(151,379)	0
Proceeds received from initial public offering, gross	149,500,000	0
Proceeds received from private placement	4,990,000	0
Offering costs paid associated with initial public offering	(3,381,654)	0
Net cash provided by financing activities	151,106,967	0
Net change in cash	775,885	(390,698)
Cash - beginning of the period	0	775,885
Cash - end of the period	775,885	385,187
Supplemental disclosure of noncash investing and financing activities:
Extinguishment of deferred underwriting commissions allocated to public shares	0	2,616,250
Offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares	25,000	0
Offering costs included in accrued expenses	70,000	0
Deferred underwriting commissions	$ 5,232,500	$ 0

Description of Organization and

Description of Organization and Business Operations	12 Months Ended
Description of Organization and Business Operations	Dec. 31, 2022
Description of Organization and Business Operations [Abstract]
Description of Organization and Business Operations	Note 1 - Description of Organization and Business Operations ARYA Sciences Acquisition Corp V (the “Company”) was incorporated as a Cayman Islands exempted company on February 22, 2021. The Company was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. All activity for the period from February 22, 2021 (inception) through December 31, 2022 was related to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below, and since the Initial Public Offering, the search for a prospective initial Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is ARYA Sciences Holdings V, a Cayman Islands exempted limited company (the “Sponsor”). The registration statement for the Company’s Initial Public Offering was declared effective on July 12, 2021. On July 15, 2021, the Company consummated its Initial Public Offering of 14,950,000 Class A ordinary shares (the “Public Shares”), including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions (see Note 6). On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 499,000 Class A ordinary shares (the “Private Placement Shares”), at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million (see Note 5). Upon the closing of the Initial Public Offering and the Private Placement, $149.5 million ($10.00 per Public Share) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement were placed in a trust account (the “Trust Account”), located in the United States, with Continental Stock Transfer & Trust Company acting as trustee, and are invested only in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended (the “Investment Company Act”), having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial Business Combinations having an aggregate fair market value of at least 80% of the net assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting commissions and taxes payable on the interest earned on the Trust Account) at the time of the signing of the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. The Company will provide the holders (the “Public Shareholders”) of Public Shares, with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay income taxes). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares were classified as temporary equity in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 480, “Distinguishing Liabilities from Equity” (“ASC 480”). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, only if a majority of the ordinary shares, represented in person or by proxy and entitled to vote thereon, voted at a shareholder meeting are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to the amended and restated memorandum and articles of association which the Company will adopt upon the consummation of the Initial Public Offering (the “Amended and Restated Memorandum and Articles of Association”), conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transactions is required by law, or the Company decides to obtain shareholder approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks shareholder approval in connection with a Business Combination, the initial shareholders (as defined below) agreed to vote their Founder Shares (as defined below in Note 5) and any Public Shares they hold in favor of a Business Combination. Subsequent to the consummation of the Initial Public Offering, the Company will adopt an insider trading policy which will require insiders to: (i) refrain from purchasing shares during certain blackout periods and when they are in possession of any material non-public information and (ii) to clear all trades with the Company’s legal counsel prior to execution. In addition, the initial shareholders agreed to waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of a Business Combination. Notwithstanding the foregoing, if the Company seeks shareholder approval of its Business Combination and does not conduct redemptions in connection with its Business Combination pursuant to the tender offer rules, the Amended and Restated Memorandum and Articles of Association provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Class A ordinary shares sold in the Initial Public Offering, without the prior consent of the Company. The Company’s Sponsor, officers and directors (the “initial shareholders”) agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (a) that would modify the substance or timing of the Company’s obligation to provide holders of its Public Shares the right to have their shares redeemed in connection with a Business Combination or to redeem 100% of the Company’s Public Shares if the Company does not complete its Business Combination within 24 months from the closing of the Initial Public Offering, or July 15, 2023, (the “Combination Period”), or (b) with respect to any other provision relating to the rights of Public Shareholders, unless the Company provides the Public Shareholders with the opportunity to redeem their Class A ordinary shares in conjunction with any such amendment. If the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than ten The initial shareholders agreed to waive their liquidation rights with respect to the Founder Shares and Private Placement Shares held by them if the Company fails to complete a Business Combination within the Combination Period. However, if the initial shareholders acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account. In order to protect the amounts held in the Trust Account, the Sponsor agreed to be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00 per Public Share and (ii) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account if less than $10.00 per Public Share due to reductions in the value of the assets in the Trust Account, in each case net of the interest that may be withdrawn to pay for the Company’s tax obligations. This liability will not apply with respect to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the Trust Account or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (excluding the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account. The Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor’s only assets are securities of the Company. The Sponsor may not be able to satisfy those obligations. None of the Company’s officers or directors will indemnify the Company for claims by third parties including, without limitation, claims by vendors and prospective target businesses. Going Concern As of December 31, 2022, the Company had approximately $385,000 in its operating bank account, and working capital deficit of approximately $2.3 million. The Company’s liquidity needs to date have been satisfied through a contribution of $25,000 from Sponsor to cover for certain expenses in exchange for the issuance of the Founder Shares, the loan of approximately $151,000 from the Sponsor pursuant to the Note (as defined in Note 5) and advances from the Sponsor, and $2 million in proceeds from the consummation of the Private Placement not held in the Trust Account. The Company fully repaid the Note on July 15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (as defined in Note 5). As of December 31, 2022 and 2021, there were no amounts outstanding under any Working Capital Loan. The Company cannot provide any assurance that new financing along the lines detailed above will be available to it on commercially acceptable terms, if at all. Further, the Company has until July 15, 2023 to consummate a Business Combination, but the Company cannot provide assurance that it will be able to consummate a Business Combination by that date. If a Business Combination is not consummated by the required date, there will be a mandatory liquidation and subsequent dissolution. In connection with the Company’s assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Basis of Presentation - Going Concern,” management has determined that the working capital deficit quidity conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate, July 15, 2023. The financial statements do not include any adjustment that might be necessary if the Company is unable to continue as a going concern. No adjustments have been made to the carrying amounts of assets and liabilities should the Company be required to liquidate after July 15, 2023, nor do these financial statements include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.

Restatement of Previously Issue

Restatement of Previously Issued Financial Statements	12 Months Ended
Restatement of Previously Issued Financial Statements	Dec. 31, 2022
Restatement of Previously Issued Financial Statements [Abstract]
Restatement of Previously Issued Financial Statements	Note 2 – Restatement of Previously Issued Financial Statements On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its % share (the “Waiver”) of the deferred underwriting commissions (the “Deferred Commissions”), which were payable upon completion of an initial and deposited into the trust account established in connection with the Company’s Initial Public Offering. In connection with the Waiver, the underwriter also agreed that (i) the Waiver is not intended to allocate its % portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Historically, the Company had recognized a liability upon closing of its Initial Public Offering in July 2021 for a portion of the Deferred Commissions which was contingently payable upon closing of a future Business Combination, with the offsetting entry resulting in an initial discount to the securities sold in the Initial Public Offering. In its previously issued unaudited condensed financial statements as of and for the period ended September 30, 2022 (the “Quarterly Report”), the Company recognized the Waiver as an extinguishment, with a resulting non-operating gain recognized in its statement of operations. Upon subsequent review and analysis, management concluded that the Company should have recognized the extinguishment of the contingent liability as a credit to shareholders’ deficit. Therefore, the Company’s management and the Audit Committee of the Company’s Board of Directors (the “Audit Committee”) concluded that the financial statements as of and for the period ended September 30, 2022 (the “Affected Period”) included in the Quarterly Report should no longer be relied upon and that it is appropriate to restate the financial statements included in the Quarterly Report. As such, the Company has decided to restate the financial statements included in the Quarterly Report in this Report. Impact of the Restatement The impact of the restatement on the statements of operations, statements of changes in shareholders’ deficit and statements of cash flows for the Affected Period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. Statements of Operations: For the three months ended September 30, 2022 (unaudited) As Previously Reported Restatement Adjustment As Restated General and administrative expenses $ 163,022 $ - $ 163,022 Loss from operations (163,022 ) - (163,022 ) Other income Gain from settlement of deferred underwriting commissions 2,616,250 (2,616,250 ) - Unrealized gain on investments held in Trust Account 661,899 - 661,899 Total other income 3,278,149 (2,616,250 ) 661,899 Net income $ 3,115,127 $ (2,616,250 ) $ 498,877 Basic and diluted weighted average shares outstanding of Class A ordinary shares 15,449,000 15,449,000 Basic and diluted net income per share, Class A ordinary share $ 0.16 $ (0.14 ) $ 0.02 Basic and diluted weighted average shares outstanding of Class B ordinary shares 3,737,500 3,737,500 Basic and diluted net income per share, Class B ordinary share $ 0.16 $ (0.14 ) $ 0.02 For the nine months ended September 30, 2022 (unaudited) As Previously Reported Restatement Adjustment As Restated General and administrative expenses $ 627,680 $ - $ 627,680 Loss from operations (627,680 ) - (627,680 ) Other income Gain from settlement of deferred underwriting commissions 2,616,250 (2,616,250 ) - Unrealized gain on investments held in Trust Account 849,701 - 849,701 Total other income 3,465,951 (2,616,250 ) 849,701 Net income $ 2,838,271 $ (2,616,250 ) $ 222,021 Basic and diluted weighted average shares outstanding of Class A ordinary shares 15,449,000 15,449,000 Basic and diluted net income per share, Class A ordinary share $ 0.15 $ (0.14 ) $ 0.01 Basic and diluted weighted average shares outstanding of Class B ordinary shares 3,737,500 3,737,500 Basic and diluted net income per share, Class B ordinary share $ 0.15 $ (0.14 ) $ 0.01 Statements of Changes in Shareholders’ Deficit: For the three months ended September 30, 2022 Ordinary Shares Additional Paid-in Capital Accumulated Deficit Total Shareholder's Deficit Class A Class B As Previously Reported Restatement Adjustment As Restated Shares Amount Shares Amount Balance - June 30, 2022 (unaudited) 499,000 $ 50 3,737,500 $ 374 $ - $ (7,077,018 ) $ - $ (7,077,018 ) $ (7,076,594 ) Adjustment of accretion of Class A ordinary shares subject to possible redemption - - - - - (661,899 ) 2,616,250 1,954,351 1,954,351 Net income - - - - - 3,115,127 (2,616,250 ) 498,877 498,877 Balance - September 30, 2022 (unaudited) 499,000 $ 50 3,737,500 $ 374 $ - $ (4,623,790 ) $ - $ (4,623,790 ) $ (4,623,366 ) For the nine months ended September 30, 2022 Ordinary Shares Additional Paid-in Capital Accumulated Deficit Total Shareholder's Deficit Class A Class B As Previously Reported Restatement Adjustment As Restated Shares Amount Shares Amount Balance - December 31, 2021 499,000 $ 50 3,737,500 $ 374 $ - $ (6,681,846 ) $ - $ (6,681,846 ) $ (6,681,422 ) Adjustment of accretion of Class A ordinary shares subject to possible redemption - - - - - (780,215 ) 2,616,250 1,836,035 1,836,035 Net income - - - - - 2,838,271 (2,616,250 ) 222,021 222,021 Balance - September 30, 2022 (unaudited) 499,000 $ 50 3,737,500 $ 374 $ - $ (4,623,790 ) $ - $ (4,623,790 ) $ (4,623,366 ) Statements of Cash Flows: For the nine months ended September 30, 2022 (unaudited) As Previously Reported Restatement Adjustment As Restated Cash Flows from Operating Activities: Net income $ 2,838,271 $ (2,616,250) ) $ 222,021 Adjustments to reconcile net income to net cash used in operating activities: Gain from settlement of deferred underwriting commissions (2,616,250) ) 2,616,250 - Unrealized gain on investments held in Trust Account (849,701) ) (849,701) ) Changes in operating assets and liabilities: - Prepaid expenses 211,620 211,620 Accounts payable 78 78 Accrued expenses (725) ) (725) ) Due to related party 60,000 60,000 Net cash used in operating activities (356,707) ) - (356,707) ) Net change in cash (356,707) ) - (356,707) ) Cash - beginning of the period 775,885 - 775,885 Cash - end of the period $ 419,178 $ - $ 419,178 Supplemental disclosure of noncash activities: Extinguishment of deferred underwriting commissions allocated to public shares $ - $ 2,616,250 $ 2,616,250

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 3 - Summary of Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Concentration of Cash Balances The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021, aside from the cash maintained in the Trust Account (see Note 9). Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets liabilities and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates. Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income and unrealized gain on investments held in Trust Account in the accompanying audited statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information. Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets. Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2022 and 2021, the carrying values of cash, accounts payable, accrued expenses and due to related party approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less and are recognized at fair value. The fair value of marketable securities held in Trust Account is determined using quoted prices in active markets. Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities. Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ deficit. The Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, 14,950,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit. Income Taxes FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2022 and 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2022 and 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. Net Income (Loss) per Ordinary Share The Company has two classes of shares: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per ordinary share as the redemption value approximates fair value. For the Year Ended December 31, 2022 For the period from February 22, 2021 (inception) through December 31, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ 978,466 $ 236,716 $ (2,148,447 ) $ (838,821 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 15,449,000 3,737,500 8,390,831 3,514,776 Basic and diluted net income (loss) per ordinary share $ 0.06 $ 0.06 $ (0.25 ) $ (0.25 ) Recent Accounting Pronouncements The Company’s management does not believe there are any recently issued, but not yet effective, accounting pronouncements if currently adopted would have a material effect on the Company’s financial statements.

Initial Public Offering

Initial Public Offering	12 Months Ended
Initial Public Offering	Dec. 31, 2022
Initial Public Offering [Abstract]
Initial Public Offering	Note 4 - Initial Public Offering On July 15, 2021, the Company consummated its Initial Public Offering of 14,950,000 Public Shares, including the 1,950,000 Public Shares as a result of the underwriters’ full exercise of their over-allotment option, at an offering price of $10.00 per Public Share, generating gross proceeds of $149.5 million, and incurring offering costs of approximately $8.7 million, inclusive of approximately $5.2 million in deferred underwriting commissions. On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination.

Related Party Transactions

Related Party Transactions	12 Months Ended
Related Party Transactions	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Note 5 - Related Party Transactions Founder Shares On March 18, 2021, the Sponsor paid $25,000 to cover certain of the Company’s expenses in exchange for the issuance of 3,737,500 Class B ordinary shares, par value $0.0001 (the “Founder Shares”). In June 2021, the Sponsor transferred an aggregate of 120,000 Founder Shares to the Company’s independent director nominees. The Sponsor agreed to forfeit up to 487,500 Founder Shares to the extent that the over-allotment option was not exercised in full by the underwriters, so that the Founder Shares would represent 20.0% of the Company’s issued and outstanding ordinary shares (excluding the Private Placement Shares) after the Initial Public Offering. On July 15, 2021, the underwriters fully exercised the over-allotment option to purchase additional 1,950,000 Public Shares. As a result, the 487,500 Class B ordinary shares were no longer subject to forfeiture. The initial shareholders agreed, subject to limited exceptions, not to transfer, assign or sell any of their Founder Shares until the earlier to occur of: (A) one year after the completion of the initial Business Combination and (B) subsequent to the initial Business Combination, (x) if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Public Shareholders having the right to exchange their ordinary shares for cash, securities or other property. Private Placement Shares Simultaneously with the closing of the Initial Public Offering, the Company consummated the Private Placement of 499,000 Private Placement Shares, at a price of $10.00 per Private Placement Share to the Sponsor, generating gross proceeds of approximately $5.0 million. Certain proceeds from the Private Placement Shares were added to the proceeds from the Initial Public Offering held in the Trust Account. The Private Placement Shares were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act. The Private Placement Shares are not transferable or salable until 30 days after the completion of the initial Business Combination. Certain proceeds from the Private Placement Shares have been added to the proceeds from the Initial Public Offering held in the Trust Account. The Sponsor and the Company’s officers and directors agreed, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Shares until 30 days after the completion of the initial Business Combination. Related Party Loans On March 31, 2021, a related party advanced approximately $1,400 to cover for certain expenses on behalf of the Company. The Company fully repaid the advance from related party of approximately $1,400 on April 5, 2021. On March 18, 2021, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover for expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing and payable upon the completion of the Initial Public Offering. The Company borrowed $150,000 under the Note and fully repaid the Note amount on July 15, 2021. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon the consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into shares of the post Business Combination entity at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of December 31, 2022 and 2021, the Company had no outstanding borrowings under the Working Capital Loans. Administrative Support Agreement Commencing on the date that the Company’s registration statement relating to its Initial Public Offering was declared effective through the earlier of consummation of the initial Business Combination and the Company’s liquidation, the Company agreed to reimburse the Sponsor for office space, secretarial and administrative services provided to the Company in the amount of $10,000 per month. For the year ended December 31, 2022 and for the period from February 22, 2021 (inception) through December 31, 2021, the Company incurred expenses of approximately $120,000 and $56,000, respectively, under this agreement. As of December 31, 2022 and 2021, the Company had $90,000 and $0, respectively, in due to related party on the balance sheets.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
Commitments and Contingencies	Dec. 31, 2022
Commitments and Contingencies [Abstract]
Commitments and Contingencies	Note 6 - Commitments and Contingencies Registration Rights The holders of Founder Shares, and Private Placement Shares, including Private Placement Shares that may be issued upon conversion of Working Capital Loans, are entitled to registration rights pursuant to a registration and shareholder rights agreement signed upon the consummation of the Initial Public Offering. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of its Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lock-up period, which occurs (i) in the case of the Founder Shares, in accordance with the letter agreement the Company’s initial shareholders entered into and (ii) in the case of the Private Placement Shares, 30 days after the completion of the Company’s Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriting Agreement The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 1,950,000 additional Public Shares to cover over-allotments at the Initial Public Offering price less the underwriting discounts and commissions. On July 15, 2021, the underwriters fully exercised the over-allotment option. The underwriters were paid an underwriting discount of $0.20 per Public Share, or approximately $3.0 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per Public Share, or approximately $5.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. On August 8, 2022, the Company received a waiver from one of the underwriters of its Initial Public Offering pursuant to which such underwriter waived all rights to its 50% share of the deferred underwriting commissions payable upon completion of an initial Business Combination. In connection with this waiver, the underwriter also agreed that (i) this waiver is not intended to allocate its 50% portion of the deferred underwriting commissions to the other underwriter that has not waived its right to receive its share of the deferred underwriting commissions and (ii) the waived portion of the deferred underwriting commissions can, at the discretion of the Company, be paid to one or more parties or otherwise be used in connection with an initial Business Combination. During the year ended December 31, 2022, the Company derecognized approximately $2.6 million of the deferred underwriting commissions and recorded an adjustment to the carrying value of the shares of Class A ordinary shares subject to possible redemption. Risks and Uncertainties Management continues to evaluate the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily determinable as of the date of the financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. The impact of this action and related sanctions on the world economy is not determinable as of the date of this report, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of this report.

Class A Ordinary Shares Subject

Class A Ordinary Shares Subject to Possible Redemption	12 Months Ended
Class A Ordinary Shares Subject to Possible Redemption	Dec. 31, 2022
Class A Ordinary Shares Subject to Possible Redemption [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	Note 7 - Class A Ordinary Shares Subject to Possible Redemption The Company’s Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. As of December 31, 2022 and 2021, there were 14,950,000 Class A ordinary shares subject to possible redemption. The Public Shares issued in the Initial Public Offering exercise by the underwriters of the over-allotment option were recognized in Class A ordinary shares subject to possible redemption as follows: Gross proceeds $ 149,500,000 Less: Offering costs allocated to Class A ordinary shares subject to possible redemption (8,709,154 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 8,709,154 Class A ordinary shares subject to possible redemption at December 31, 2021 149,500,000 Plus: Waiver of defreed underwriting commission 2,616,250 Less Adjustment for accretion of Class A ordinary shares subject to possible redemption (614,529) Class A ordinary shares subject to possible redemption at December 31, 2022 $ 151,501,721

Shareholders' Deficit

Shareholders' Deficit	12 Months Ended
Shareholders' Deficit	Dec. 31, 2022
Shareholders' Deficit [Abstract]
Shareholders' Deficit (Deficit)	Note 8 - Shareholders’ Deficit Preference Shares Class A Ordinary Shares - Class B Ordinary Shares Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders at a general meeting of the Company. Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the shareholders except as required by law. The Class B ordinary shares will automatically convert into Class A ordinary shares on the first business day following the consummation of the initial Business Combination at a ratio such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an as-converted basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding (excluding the Private Placement Shares) upon the consummation of the Initial Public Offering, plus (ii) the sum of the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Shares issued to the Sponsor, members of the Company’s management team or any of their affiliates upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than one-to-one.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2022
Fair Value Measurements [Abstract]
Fair Value Measurements	Note The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: December 31, 2022 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets held in Trust Account: U.S. Treasury Securities $ 151,592,810 $ - $ - Cash equivalents - money market funds 8,911 - - $ 151,601,721 $ - $ - December 31, 2021 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets held in Trust Account: U.S. Treasury Securities $ 149,523,037 $ - $ - Cash equivalents - money market funds 7,477 - - $ 149,530,514 $ - $ - Transfers to/from Levels 1, 2, and 3 are recognized at the end of the reporting period. There were no transfers between levels of the hierarchy for the years ended December 31, 2022 and for the period from February 22, 2021 (inception) through December 31, 2021. Level 1 instruments include investments U.S. Treasury securities with an original maturity of 185 days or less.

Subsequent Events

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 10 - Subsequent Events The Company evaluated subsequent events and transactions that occurred up to the date the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the SEC.
Concentration of Cash Balances	Concentration of Cash Balances The Company has significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.
Cash and Cash Equivalents	Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of December 31, 2022 and 2021, aside from the cash maintained in the Trust Account (see Note 9).
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets liabilities and expenses and disclosure of contingent assets and liabilities at the date of the financial statements. Actual results could differ from those estimates.
Investments Held in Trust Account	Investments Held in Trust Account The Company’s portfolio of investments is comprised of U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less, or investments in money market funds that invest in U.S. government securities and generally have a readily determinable fair value, or a combination thereof. When the Company’s investments held in the Trust Account are comprised of U.S. government securities, the investments are classified as trading securities. When the Company’s investments held in the Trust Account are comprised of money market funds, the investments are recognized at fair value. Trading securities and investments in money market funds are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of these securities are included in interest income and unrealized gain on investments held in Trust Account in the accompanying audited statements of operations. The estimated fair values of investments held in the Trust Account are determined using available market information.
Financial Instruments	Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheets.
Fair Value Measurements	Fair Value Measurements Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. U.S. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers consist of: • Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; • Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and • Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement. As of December 31, 2022 and 2021, the carrying values of cash, accounts payable, accrued expenses and due to related party approximate their fair values due to the short-term nature of the instruments. The Company’s investments held in Trust Account are comprised of investments in U.S. Treasury securities with an original maturity of 185 days or less and are recognized at fair value. The fair value of marketable securities held in Trust Account is determined using quoted prices in active markets.
Offering Costs Associated with the Initial Public Offering	Offering Costs Associated with the Initial Public Offering Offering costs consisted of legal, accounting, underwriting and other costs incurred that were directly related to the Initial Public Offering. Offering costs were allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with the Class A ordinary shares issued were charged against the carrying value of the Class A ordinary shares subject to possible redemption upon the completion of the Initial Public Offering. The Company classifies deferred underwriting commissions as non-current liabilities as their liquidation is not reasonably expected to require the use of current assets or require the creation of current liabilities.
Class A Ordinary Shares Subject to Possible Redemption	Class A Ordinary Shares Subject to Possible Redemption The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Class A ordinary shares subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. Conditionally redeemable Class A ordinary shares (including Class A ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, Class A ordinary shares are classified as shareholders’ deficit. The Public Shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of December 31, 2022 and 2021, 14,950,000 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheets. The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of the Class A ordinary shares subject to possible redemption to equal the redemption value at the end of each reporting period. This method would view the end of the reporting period as if it were also the redemption date for the security. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption amount, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
Income Taxes	Income Taxes FASB ASC Topic 740, “Income Taxes,” prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of December 31, 2022 and 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of December 31, 2022 and 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. There is currently no taxation imposed on income by the government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Net Income (Loss) per Ordinary Share	Net Income (Loss) per Ordinary Share The Company has two classes of shares: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per ordinary share as the redemption value approximates fair value. For the Year Ended December 31, 2022 For the period from February 22, 2021 (inception) through December 31, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ 978,466 $ 236,716 $ (2,148,447 ) $ (838,821 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 15,449,000 3,737,500 8,390,831 3,514,776 Basic and diluted net income (loss) per ordinary share $ 0.06 $ 0.06 $ (0.25 ) $ (0.25 )
Recent Accounting Pronouncements	Recent Accounting Pronouncements The Company’s management does not believe there are any recently issued, but not yet effective, accounting pronouncements if currently adopted would have a material effect on the Company’s financial statements.

Restatement of Previously Iss_2

Restatement of Previously Issued Financial Statements (Tables)	12 Months Ended
	Dec. 31, 2022
Restatement of Previously Issued Financial Statements [Abstract]
Restatement of Previously Issued Financial Statement	The impact of the restatement on the statements of operations, statements of changes in shareholders’ deficit and statements of cash flows for the Affected Period is presented below. The restatement had no impact on net cash flows from operating, investing or financing activities. Statements of Operations: For the three months ended September 30, 2022 (unaudited) As Previously Reported Restatement Adjustment As Restated General and administrative expenses $ 163,022 $ - $ 163,022 Loss from operations (163,022 ) - (163,022 ) Other income Gain from settlement of deferred underwriting commissions 2,616,250 (2,616,250 ) - Unrealized gain on investments held in Trust Account 661,899 - 661,899 Total other income 3,278,149 (2,616,250 ) 661,899 Net income $ 3,115,127 $ (2,616,250 ) $ 498,877 Basic and diluted weighted average shares outstanding of Class A ordinary shares 15,449,000 15,449,000 Basic and diluted net income per share, Class A ordinary share $ 0.16 $ (0.14 ) $ 0.02 Basic and diluted weighted average shares outstanding of Class B ordinary shares 3,737,500 3,737,500 Basic and diluted net income per share, Class B ordinary share $ 0.16 $ (0.14 ) $ 0.02 For the nine months ended September 30, 2022 (unaudited) As Previously Reported Restatement Adjustment As Restated General and administrative expenses $ 627,680 $ - $ 627,680 Loss from operations (627,680 ) - (627,680 ) Other income Gain from settlement of deferred underwriting commissions 2,616,250 (2,616,250 ) - Unrealized gain on investments held in Trust Account 849,701 - 849,701 Total other income 3,465,951 (2,616,250 ) 849,701 Net income $ 2,838,271 $ (2,616,250 ) $ 222,021 Basic and diluted weighted average shares outstanding of Class A ordinary shares 15,449,000 15,449,000 Basic and diluted net income per share, Class A ordinary share $ 0.15 $ (0.14 ) $ 0.01 Basic and diluted weighted average shares outstanding of Class B ordinary shares 3,737,500 3,737,500 Basic and diluted net income per share, Class B ordinary share $ 0.15 $ (0.14 ) $ 0.01 Statements of Changes in Shareholders’ Deficit: For the three months ended September 30, 2022 Ordinary Shares Additional Paid-in Capital Accumulated Deficit Total Shareholder's Deficit Class A Class B As Previously Reported Restatement Adjustment As Restated Shares Amount Shares Amount Balance - June 30, 2022 (unaudited) 499,000 $ 50 3,737,500 $ 374 $ - $ (7,077,018 ) $ - $ (7,077,018 ) $ (7,076,594 ) Adjustment of accretion of Class A ordinary shares subject to possible redemption - - - - - (661,899 ) 2,616,250 1,954,351 1,954,351 Net income - - - - - 3,115,127 (2,616,250 ) 498,877 498,877 Balance - September 30, 2022 (unaudited) 499,000 $ 50 3,737,500 $ 374 $ - $ (4,623,790 ) $ - $ (4,623,790 ) $ (4,623,366 ) For the nine months ended September 30, 2022 Ordinary Shares Additional Paid-in Capital Accumulated Deficit Total Shareholder's Deficit Class A Class B As Previously Reported Restatement Adjustment As Restated Shares Amount Shares Amount Balance - December 31, 2021 499,000 $ 50 3,737,500 $ 374 $ - $ (6,681,846 ) $ - $ (6,681,846 ) $ (6,681,422 ) Adjustment of accretion of Class A ordinary shares subject to possible redemption - - - - - (780,215 ) 2,616,250 1,836,035 1,836,035 Net income - - - - - 2,838,271 (2,616,250 ) 222,021 222,021 Balance - September 30, 2022 (unaudited) 499,000 $ 50 3,737,500 $ 374 $ - $ (4,623,790 ) $ - $ (4,623,790 ) $ (4,623,366 ) Statements of Cash Flows: For the nine months ended September 30, 2022 (unaudited) As Previously Reported Restatement Adjustment As Restated Cash Flows from Operating Activities: Net income $ 2,838,271 $ (2,616,250) ) $ 222,021 Adjustments to reconcile net income to net cash used in operating activities: Gain from settlement of deferred underwriting commissions (2,616,250) ) 2,616,250 - Unrealized gain on investments held in Trust Account (849,701) ) (849,701) ) Changes in operating assets and liabilities: - Prepaid expenses 211,620 211,620 Accounts payable 78 78 Accrued expenses (725) ) (725) ) Due to related party 60,000 60,000 Net cash used in operating activities (356,707) ) - (356,707) ) Net change in cash (356,707) ) - (356,707) ) Cash - beginning of the period 775,885 - 775,885 Cash - end of the period $ 419,178 $ - $ 419,178 Supplemental disclosure of noncash activities: Extinguishment of deferred underwriting commissions allocated to public shares $ - $ 2,616,250 $ 2,616,250

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
Summary of Significant Accounting Policies (Tables)	Dec. 31, 2022
Summary of Significant Accounting Policies [Abstract]
Basic and Diluted Net Income (Loss) Per Common Share	The Company has two classes of shares: Class A ordinary shares and Class B ordinary shares. Income and losses are shared pro rata between the two classes of shares. Net income (loss) per ordinary share is computed by dividing net income (loss) by the weighted-average number of ordinary shares outstanding during the periods. Accretion associated with the Class A ordinary shares subject to possible redemption is excluded from earnings per ordinary share as the redemption value approximates fair value. For the Year Ended December 31, 2022 For the period from February 22, 2021 (inception) through December 31, 2021 Class A Class B Class A Class B Basic and diluted net income (loss) per ordinary share: Numerator: Allocation of net income (loss) $ 978,466 $ 236,716 $ (2,148,447 ) $ (838,821 ) Denominator: Basic and diluted weighted average ordinary shares outstanding 15,449,000 3,737,500 8,390,831 3,514,776 Basic and diluted net income (loss) per ordinary share $ 0.06 $ 0.06 $ (0.25 ) $ (0.25 )

Class A Ordinary Shares Subje_2

Class A Ordinary Shares Subject to Possible Redemption (Tables)	12 Months Ended
	Dec. 31, 2022
Class A Ordinary Shares Subject to Possible Redemption [Abstract]
Class A Ordinary Shares Subject to Possible Redemption	The Public Shares issued in the Initial Public Offering exercise by the underwriters of the over-allotment option were recognized in Class A ordinary shares subject to possible redemption as follows: Gross proceeds $ 149,500,000 Less: Offering costs allocated to Class A ordinary shares subject to possible redemption (8,709,154 ) Plus: Accretion on Class A ordinary shares subject to possible redemption amount 8,709,154 Class A ordinary shares subject to possible redemption at December 31, 2021 149,500,000 Plus: Waiver of defreed underwriting commission 2,616,250 Less Adjustment for accretion of Class A ordinary shares subject to possible redemption (614,529) Class A ordinary shares subject to possible redemption at December 31, 2022 $ 151,501,721

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2022
Fair Value Measurements [Abstract]
Assets Measured on Recurring Basis	The following tables present information about the Company’s assets that are measured at fair value on a recurring basis as of December 31, 2022 and 2021 and indicate the fair value hierarchy of the valuation techniques that the Company utilized to determine such fair value: December 31, 2022 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets held in Trust Account: U.S. Treasury Securities $ 151,592,810 $ - $ - Cash equivalents - money market funds 8,911 - - $ 151,601,721 $ - $ - December 31, 2021 Description Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Other Unobservable Inputs (Level 3) Assets held in Trust Account: U.S. Treasury Securities $ 149,523,037 $ - $ - Cash equivalents - money market funds 7,477 - - $ 149,530,514 $ - $ -

Description of Organization a_2

Description of Organization and Business Operations (Details)		10 Months Ended	12 Months Ended
	Jul. 15, 2021 USD ($) $ / shares shares	Dec. 31, 2021 USD ($)	Dec. 31, 2022 USD ($) Business	Aug. 08, 2022
Initial Public Offering and Private Placement [Abstract]
Gross proceeds from initial public offering		$ 149,500,000	$ 0
Deferred offering costs associated with initial public offering	$ 8,700,000
Deferred underwriting commissions	5,200,000
Percentage of deferred underwriting commissions payable included in initial business combination				50%
Gross proceeds from private placement		4,990,000	0
Net proceeds from Initial Public Offering and Private Placement deposited in Trust Account	$ 149,500,000	149,500,000	$ 0
Unit price, Initial Public Offering and Private Placement (in dollars per unit) \| $ / shares	$ 10
Percentage of Public Shares that would not be redeemed if Business Combination is not completed within Initial Combination Period			100%
Minimum [Member]
Initial Public Offering and Private Placement [Abstract]
Number of operating businesses included in initial Business Combination \| Business			1
Fair market value as percentage of net assets held in Trust Account included in initial Business Combination			80%
Post-transaction ownership percentage of the target business			50%
Net tangible asset threshold for redeeming Public Shares			$ 5,000,001
Percentage of Public Shares that can be redeemed without prior consent			15%
Maximum [Member]
Initial Public Offering and Private Placement [Abstract]
Period to redeem Public Shares if Business Combination is not completed within Initial Combination Period			24 months
Period to cease operations if Business Combination is not completed within Combination Period			10 days
Interest from Trust Account that can be held to pay dissolution expenses			$ 100,000
Private Placement Shares [Member]
Initial Public Offering and Private Placement [Abstract]
Shares issued (in shares) \| shares	499,000
Share price (in dollars per share) \| $ / shares	$ 10
Gross proceeds from private placement	$ 5,000,000
Initial Public Offering [Member]
Initial Public Offering and Private Placement [Abstract]
Gross proceeds from initial public offering		$ 149,500,000
Initial Public Offering [Member] \| Public Shares [Member]
Initial Public Offering and Private Placement [Abstract]
Shares issued (in shares) \| shares	14,950,000
Share price (in dollars per share) \| $ / shares	$ 10
Gross proceeds from initial public offering	$ 149,500,000
Over-Allotment Option [Member] \| Public Shares [Member]
Initial Public Offering and Private Placement [Abstract]
Shares issued (in shares) \| shares	1,950,000
Share price (in dollars per share) \| $ / shares	$ 10

Description of Organization a_3

Description of Organization and Business Operations, Going Concern (Details) - USD ($)			10 Months Ended	12 Months Ended
	Jul. 15, 2021	Mar. 18, 2021	Dec. 31, 2021	Dec. 31, 2022
Going Concern [Abstract]
Cash at bank			$ 775,885	$ 385,187
Working capital				(2,300,000)
Loan proceeds			150,000	0
Private Placement Shares [Member]
Going Concern [Abstract]
Proceeds from private placement not held in Trust Account	$ 2,000,000
Sponsor [Member]
Going Concern [Abstract]
Offering expenses paid by sponsor in exchange for issuance of founder shares				25,000
Sponsor [Member] \| Promissory Note [Member]
Going Concern [Abstract]
Loan proceeds		$ 150,000		151,000
Working capital loan outstanding amount			$ 0	$ 0

Restatement of Previously Iss_3

Restatement of Previously Issued Financial Statements (Details) - USD ($)		3 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
	Aug. 08, 2022	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2022
Statement of Operations
General and administrative expenses		$ 163,022	$ 627,680	$ 3,017,782	$ 856,025
Loss from operations		(163,022)	(627,680)	(3,017,782)	(856,025)
Other income
Gain from settlement of deferred underwriting commissions	$ 2,600,000	0	0
Unrealized gain on investments held in Trust Account		661,899	849,701	30,514	2,071,207
Total other income		661,899	849,701	30,514	2,071,207
Net income (loss)		498,877	222,021	(2,987,268)	1,215,182
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(7,076,594)	(6,681,422)	0	(6,681,422)
Adjustment for accretion of Class A ordinary shares subject to possible Redemption		1,954,351	1,836,035		614,529
Net income (loss)		498,877	222,021	(2,987,268)	1,215,182
Ending balance		(4,623,366)	(4,623,366)	(6,681,422)	(4,851,711)
Cash Flows from Operating Activities:
Net income (loss)		498,877	222,021	(2,987,268)	1,215,182
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain from settlement of deferred underwriting commissions	$ (2,600,000)	0	0
Unrealized gain on investments held in Trust Account		(661,899)	(849,701)	(30,514)	(2,071,207)
Changes in operating assets and liabilities:
Prepaid expenses			211,620	(460,995)	303,995
Accounts payable			78	12,663	(1,197)
Accrued expenses			(725)	2,633,653	72,529
Due to related party			60,000	0	90,000
Net cash used in operating activities			(356,707)	(831,082)	(390,698)
Net change in cash			(356,707)	775,885	(390,698)
Cash - beginning of the period			775,885	0	775,885
Cash - end of the period		$ 419,178	419,178	775,885	385,187
Supplemental disclosure of noncash investing and financing activities:
Extinguishment of deferred underwriting commissions allocated to public shares			$ 2,616,250	$ 0	$ 2,616,250
Class A Ordinary Shares [Member]
Other income
Basic weighted average ordinary shares outstanding (in shares)		15,449,000	15,449,000	8,390,831	15,449,000
Diluted weighted average ordinary shares outstanding (in shares)		15,449,000	15,449,000	8,390,831	15,449,000
Basic net income (loss) per ordinary share (in dollars per share)		$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Diluted net income (loss) per ordinary share (in dollars per share)		$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Class B Ordinary Shares [Member]
Other income
Basic weighted average ordinary shares outstanding (in shares)		3,737,500	3,737,500	3,514,776	3,737,500
Diluted weighted average ordinary shares outstanding (in shares)		3,737,500	3,737,500	3,514,776	3,737,500
Basic net income (loss) per ordinary share (in dollars per share)		$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Diluted net income (loss) per ordinary share (in dollars per share)		$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Ordinary Shares [Member] \| Class A Ordinary Shares [Member]
Other income
Net income (loss)				$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		$ 50	$ 50	$ 0	$ 50
Beginning balance (in shares)		499,000	499,000	0	499,000
Adjustment for accretion of Class A ordinary shares subject to possible Redemption					$ 0
Net income (loss)				$ 0	0
Ending balance		$ 50	$ 50	$ 50	$ 50
Ending balance (in shares)		499,000	499,000	499,000	499,000
Cash Flows from Operating Activities:
Net income (loss)				$ 0	$ 0
Ordinary Shares [Member] \| Class B Ordinary Shares [Member]
Other income
Net income (loss)				0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		$ 374	$ 374	$ 0	$ 374
Beginning balance (in shares)		3,737,500	3,737,500	0	3,737,500
Adjustment for accretion of Class A ordinary shares subject to possible Redemption					$ 0
Net income (loss)				$ 0	0
Ending balance		$ 374	$ 374	$ 374	$ 374
Ending balance (in shares)		3,737,500	3,737,500	3,737,500	3,737,500
Cash Flows from Operating Activities:
Net income (loss)				$ 0	$ 0
Additional Paid-in Capital [Member]
Other income
Net income (loss)		$ 0	$ 0	0	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		0	0	0	0
Adjustment for accretion of Class A ordinary shares subject to possible Redemption		0	0		0
Net income (loss)		0	0	0	0
Ending balance		0	0	0	0
Cash Flows from Operating Activities:
Net income (loss)		0	0	0	0
Accumulated Deficit [Member]
Other income
Net income (loss)		498,877	222,021	(2,987,268)	1,215,182
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(7,077,018)	(6,681,846)	0	(6,681,846)
Adjustment for accretion of Class A ordinary shares subject to possible Redemption		1,954,351	1,836,035		614,529
Net income (loss)		498,877	222,021	(2,987,268)	1,215,182
Ending balance		(4,623,790)	(4,623,790)	(6,681,846)	(4,852,135)
Cash Flows from Operating Activities:
Net income (loss)		498,877	222,021	(2,987,268)	1,215,182
As Previously Reported [Member]
Statement of Operations
General and administrative expenses		163,022	627,680
Loss from operations		(163,022)	(627,680)
Other income
Gain from settlement of deferred underwriting commissions		2,616,250	2,616,250
Unrealized gain on investments held in Trust Account		661,899	849,701
Total other income		3,278,149	3,465,951
Net income (loss)		3,115,127	2,838,271
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		3,115,127	2,838,271
Cash Flows from Operating Activities:
Net income (loss)		3,115,127	2,838,271
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain from settlement of deferred underwriting commissions		(2,616,250)	(2,616,250)
Unrealized gain on investments held in Trust Account		(661,899)	(849,701)
Changes in operating assets and liabilities:
Prepaid expenses			211,620
Accounts payable			78
Accrued expenses			(725)
Due to related party			60,000
Net cash used in operating activities			(356,707)
Net change in cash			(356,707)
Cash - beginning of the period			775,885		775,885
Cash - end of the period		$ 419,178	419,178	775,885
Supplemental disclosure of noncash investing and financing activities:
Extinguishment of deferred underwriting commissions allocated to public shares			$ 0
As Previously Reported [Member] \| Class A Ordinary Shares [Member]
Other income
Basic weighted average ordinary shares outstanding (in shares)		15,449,000	15,449,000
Diluted weighted average ordinary shares outstanding (in shares)		15,449,000	15,449,000
Basic net income (loss) per ordinary share (in dollars per share)		$ 0.16	$ 0.15
Diluted net income (loss) per ordinary share (in dollars per share)		$ 0.16	$ 0.15
As Previously Reported [Member] \| Class B Ordinary Shares [Member]
Other income
Basic weighted average ordinary shares outstanding (in shares)		3,737,500	3,737,500
Diluted weighted average ordinary shares outstanding (in shares)		3,737,500	3,737,500
Basic net income (loss) per ordinary share (in dollars per share)		$ 0.16	$ 0.15
Diluted net income (loss) per ordinary share (in dollars per share)		$ 0.16	$ 0.15
As Previously Reported [Member] \| Accumulated Deficit [Member]
Other income
Net income (loss)		$ 3,115,127	$ 2,838,271
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		(7,077,018)	(6,681,846)		(6,681,846)
Adjustment for accretion of Class A ordinary shares subject to possible Redemption		(661,899)	(780,215)
Net income (loss)		3,115,127	2,838,271
Ending balance		(4,623,790)	(4,623,790)	(6,681,846)
Cash Flows from Operating Activities:
Net income (loss)		3,115,127	2,838,271
Restatement Adjustment [Member]
Statement of Operations
General and administrative expenses		0	0
Loss from operations		0	0
Other income
Gain from settlement of deferred underwriting commissions		(2,616,250)	(2,616,250)
Unrealized gain on investments held in Trust Account		0	0
Total other income		(2,616,250)	(2,616,250)
Net income (loss)		(2,616,250)	(2,616,250)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)		(2,616,250)	(2,616,250)
Cash Flows from Operating Activities:
Net income (loss)		(2,616,250)	(2,616,250)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain from settlement of deferred underwriting commissions		2,616,250	2,616,250
Unrealized gain on investments held in Trust Account		0	0
Changes in operating assets and liabilities:
Net cash used in operating activities			0
Net change in cash			0
Cash - beginning of the period			0		0
Cash - end of the period		$ 0	0	0
Supplemental disclosure of noncash investing and financing activities:
Extinguishment of deferred underwriting commissions allocated to public shares			$ 2,616,250
Restatement Adjustment [Member] \| Class A Ordinary Shares [Member]
Other income
Basic net income (loss) per ordinary share (in dollars per share)		$ (0.14)	$ (0.14)
Diluted net income (loss) per ordinary share (in dollars per share)		(0.14)	(0.14)
Restatement Adjustment [Member] \| Class B Ordinary Shares [Member]
Other income
Basic net income (loss) per ordinary share (in dollars per share)		(0.14)	(0.14)
Diluted net income (loss) per ordinary share (in dollars per share)		$ (0.14)	$ (0.14)
Restatement Adjustment [Member] \| Accumulated Deficit [Member]
Other income
Net income (loss)		$ (2,616,250)	$ (2,616,250)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance		0	0		$ 0
Adjustment for accretion of Class A ordinary shares subject to possible Redemption		2,616,250	2,616,250
Net income (loss)		(2,616,250)	(2,616,250)
Ending balance		0	0	$ 0
Cash Flows from Operating Activities:
Net income (loss)		$ (2,616,250)	$ (2,616,250)

Summary of Significant Accoun_4

Summary of Significant Accounting Policies, Cash and Cash Equivalents (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Cash and Cash Equivalents [Abstract]
Cash equivalents	$ 0	$ 0

Summary of Significant Accoun_5

Summary of Significant Accounting Policies, Class A Ordinary Shares Subject to Possible Redemption (Details) - shares	Dec. 31, 2022	Dec. 31, 2021
Class A Ordinary Shares [Member]
Common stock subject to possible redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)	14,950,000	14,950,000

Summary of Significant Accoun_6

Summary of Significant Accounting Policies, Income Taxes (Details) - USD ($)	Dec. 31, 2022	Dec. 31, 2021
Income Taxes [Abstract]
Unrecognized tax benefits	$ 0	$ 0
Accrued interest and penalties	$ 0	$ 0

Summary of Significant Accoun_7

Summary of Significant Accounting Policies, Net Income (Loss) per Ordinary Share (Details) - USD ($)	3 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2022
Class A Ordinary Shares [Member]
Numerator: [Abstract]
Allocation of net income (loss)			$ (2,148,447)	$ 978,466
Denominator: [Abstract]
Basic weighted average ordinary shares outstanding (in shares)	15,449,000	15,449,000	8,390,831	15,449,000
Diluted weighted average ordinary shares outstanding (in shares)	15,449,000	15,449,000	8,390,831	15,449,000
Basic net income (loss) per ordinary share (in dollars per share)	$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Diluted net income (loss) per ordinary share (in dollars per share)	$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Class B Ordinary Shares [Member]
Numerator: [Abstract]
Allocation of net income (loss)			$ (838,821)	$ 236,716
Denominator: [Abstract]
Basic weighted average ordinary shares outstanding (in shares)	3,737,500	3,737,500	3,514,776	3,737,500
Diluted weighted average ordinary shares outstanding (in shares)	3,737,500	3,737,500	3,514,776	3,737,500
Basic net income (loss) per ordinary share (in dollars per share)	$ 0.02	$ 0.01	$ (0.25)	$ 0.06
Diluted net income (loss) per ordinary share (in dollars per share)	$ 0.02	$ 0.01	$ (0.25)	$ 0.06

Initial Public Offering (Detail

Initial Public Offering (Details) - USD ($)		10 Months Ended	12 Months Ended
Initial Public Offering (Details) - USD ($)	Jul. 15, 2021	Dec. 31, 2021	Dec. 31, 2022	Aug. 08, 2022
Initial Public Offering [Abstract]
Gross proceeds from initial public offering		$ 149,500,000	$ 0
Deferred offering costs associated with initial public offering	$ 8,700,000
Deferred underwriting commissions	$ 5,200,000
Percentage of deferred underwriting commissions payable included in initial business combination				50%
Initial Public Offering [Member]
Initial Public Offering [Abstract]
Gross proceeds from initial public offering		$ 149,500,000
Initial Public Offering [Member] \| Public Shares [Member]
Initial Public Offering [Abstract]
Shares issued (in shares)	14,950,000
Share price (in dollars per share)	$ 10
Gross proceeds from initial public offering	$ 149,500,000
Over-Allotment Option [Member] \| Public Shares [Member]
Initial Public Offering [Abstract]
Shares issued (in shares)	1,950,000
Share price (in dollars per share)	$ 10

Related Party Transactions, Fou

Related Party Transactions, Founder Shares (Details) - USD ($)			1 Months Ended	12 Months Ended
	Jul. 15, 2021	Mar. 18, 2021	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021
Founder Shares [Abstract]
Founder shares as a percentage of issued and outstanding shares after initial public offering				20%
Over-Allotment Option [Member] \| Public Shares [Member]
Founder Shares [Abstract]
Shares issued (in shares)	1,950,000
Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, par value (in dollars per share)				$ 0.0001	$ 0.0001
Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Ordinary shares, par value (in dollars per share)		$ 0.0001		$ 0.0001	$ 0.0001
Sponsor [Member] \| Class A Ordinary Shares [Member]
Founder Shares [Abstract]
Number of trading days				20 days
Trading day threshold period				30 days
Sponsor [Member] \| Class A Ordinary Shares [Member] \| Minimum [Member]
Founder Shares [Abstract]
Share price (in dollars per share)				$ 12
Threshold period after initial Business Combination				150 days
Sponsor [Member] \| Class B Ordinary Shares [Member]
Founder Shares [Abstract]
Proceeds from issuance of common stock		$ 25,000
Shares issued (in shares)		3,737,500
Founder shares as a percentage of issued and outstanding shares after initial public offering		20%
Number of shares no longer subject to forfeiture (in shares)	487,500
Period to not transfer, assign or sell Founder Shares				1 year
Sponsor [Member] \| Class B Ordinary Shares [Member] \| Maximum [Member]
Founder Shares [Abstract]
Shares subject to forfeiture (in shares)		487,500
Independent Director Nominees [Member]
Founder Shares [Abstract]
Shares issued (in shares)			120,000

Related Party Transactions, Pri

Related Party Transactions, Private Placement Shares (Details) - USD ($)		10 Months Ended	12 Months Ended
	Jul. 15, 2021	Dec. 31, 2021	Dec. 31, 2022
Private Placement [Abstract]
Gross proceeds from private placement		$ 4,990,000	$ 0
Private Placement Shares [Member]
Private Placement [Abstract]
Shares issued (in shares)	499,000
Share price (in dollars per share)	$ 10
Gross proceeds from private placement	$ 5,000,000
Number of days shares are transferrable after completion of initial business combination			30 days
Sponsor [Member] \| Private Placement Shares [Member]
Private Placement [Abstract]
Shares issued (in shares)	499,000
Share price (in dollars per share)	$ 10
Gross proceeds from private placement	$ 5,000,000

Related Party Transactions, Rel

Related Party Transactions, Related Party Loans and Administrative Support Agreement (Details) - USD ($)					3 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
	Jul. 15, 2021	Apr. 05, 2021	Mar. 31, 2021	Mar. 18, 2021	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2022
Related Party Loans [Abstract]
Repayment to related party							$ 151,379	$ 0
Loan proceeds							150,000	0
Administrative Support Agreement [Abstract]
Related party expense					$ 163,022	$ 627,680	3,017,782	856,025
Due to related party							0	90,000
Sponsor [Member] \| Promissory Note [Member]
Related Party Loans [Abstract]
Related party transaction				$ 300,000
Repayment to related party	$ 150,000
Loan proceeds				$ 150,000				151,000
Sponsor [Member] \| Administrative Support Agreement [Member]
Administrative Support Agreement [Abstract]
Monthly fee								10,000
Related party expense							56,000	120,000
Due to related party							0	90,000
Sponsor [Member] \| Advance [Member]
Related Party Loans [Abstract]
Related party transaction			$ 1,400
Repayment to related party		$ 1,400
Sponsor Affiliate of Sponsor or Certain Company Officers and Directors [Member] \| Working Capital Loans [Member]
Related Party Loans [Abstract]
Conversion value								$ 1,500,000
Conversion price (in dollars per share)								$ 10
Borrowings outstanding							$ 0	$ 0

Commitments and Contingencies,

Commitments and Contingencies, Registration Rights (Details)	Dec. 31, 2022 Demand
Registration Rights [Abstract]
Number of demands eligible security holder can make	3

Commitments and Contingencies_2

Commitments and Contingencies, Underwriting Agreement (Details) - USD ($)			3 Months Ended	9 Months Ended	12 Months Ended
	Aug. 08, 2022	Jul. 15, 2021	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2022
Underwriting Agreement [Abstract]
Term of option for underwriters to purchase additional Units to cover over-allotments					45 days
Additional shares that can be purchased to cover over-allotments (in shares)		1,950,000
Underwriting discount (in dollars per share)		$ 0.2
Underwriting discount		$ 3,000,000
Deferred underwriting commissions (in dollars per share)		$ 0.35
Deferred underwriting commissions		$ 5,200,000
Percentage of deferred underwriting commissions payable included in initial business combination	50%
Gain from settlement of deferred underwriting commissions	$ 2,600,000		$ 0	$ 0

Class A Ordinary Shares Subje_3

Class A Ordinary Shares Subject to Possible Redemption (Details) - USD ($)	3 Months Ended	9 Months Ended	10 Months Ended	12 Months Ended
	Sep. 30, 2022	Sep. 30, 2022	Dec. 31, 2021	Dec. 31, 2022	Jul. 15, 2021
Common Stock Subject To Possible Redemption [Abstract]
Gross proceeds from initial public offering			$ 149,500,000	$ 0
Offering costs paid associated with initial public offering					$ (8,700,000)
Waiver of deferred underwriting commissions		$ 2,616,250	0	2,616,250
Adjustment for accretion of Class A ordinary shares subject to possible Redemption	$ 1,954,351	$ 1,836,035		614,529
Class A ordinary shares subject to possible redemption			$ 149,500,000	$ 151,501,721
Class A Ordinary Shares [Member]
Common Stock Subject To Possible Redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)			14,950,000	14,950,000
Initial Public Offering [Member]
Common Stock Subject To Possible Redemption [Abstract]
Gross proceeds from initial public offering			$ 149,500,000
Initial Public Offering [Member] \| Class A Ordinary Shares [Member]
Common Stock Subject To Possible Redemption [Abstract]
Ordinary shares subject to possible redemption (in shares)			14,950,000	14,950,000
Offering costs paid associated with initial public offering			$ (8,709,154)
Accretion on Class A ordinary shares subject to possible redemption amount			8,709,154
Adjustment for accretion of Class A ordinary shares subject to possible Redemption				$ (614,529)
Class A ordinary shares subject to possible redemption			$ 149,500,000	$ 151,501,721

Shareholders' Deficit (Details)

Shareholders' Deficit (Details)	12 Months Ended
Shareholders' Deficit (Details)	Dec. 31, 2022 Vote $ / shares shares	Dec. 31, 2021 $ / shares shares	Mar. 18, 2021 $ / shares
Stockholders' Deficit [Abstract]
Preference shares, shares authorized (in shares)	1,000,000	1,000,000
Preference shares, shares issued (in shares)	0	0
Preference shares, shares outstanding (in shares)	0	0
Voting rights per share \| Vote	1
Founder shares as a percentage of issued and outstanding shares after initial public offering	20%
Stock conversion basis at time of business combination	1
Class A Ordinary Shares [Member]
Stockholders' Deficit [Abstract]
Ordinary shares, shares authorized (in shares)	479,000,000	479,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001
Voting rights per share \| Vote	1
Ordinary shares, shares issued (in shares)	15,449,000	15,449,000
Ordinary shares, shares outstanding (in shares)	15,449,000	15,449,000
Ordinary shares, shares issued (in shares)	499,000	499,000
Ordinary shares, shares outstanding (in shares)	499,000	499,000
Ordinary shares subject to possible redemption (in shares)	14,950,000	14,950,000
Class B Ordinary Shares [Member]
Stockholders' Deficit [Abstract]
Ordinary shares, shares authorized (in shares)	20,000,000	20,000,000
Ordinary shares, par value (in dollars per share) \| $ / shares	$ 0.0001	$ 0.0001	$ 0.0001
Ordinary shares, shares issued (in shares)	3,737,500	3,737,500
Ordinary shares, shares outstanding (in shares)	3,737,500	3,737,500

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($)	10 Months Ended	12 Months Ended
Fair Value Measurements (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2022
Investments held in Trust Account [Abstract]
Transfers in into Level 3	$ 0	$ 0
Transfers out of Level 3	0	$ 0
Maximum [Member]
Investments held in Trust Account [Abstract]
Investment maturity period		185 days
Recurring [Member] \| Quoted Prices in Active Markets (Level 1) [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	149,530,514	$ 151,601,721
Recurring [Member] \| Quoted Prices in Active Markets (Level 1) [Member] \| US Treasury Securities [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	149,523,037	151,592,810
Recurring [Member] \| Quoted Prices in Active Markets (Level 1) [Member] \| Cash Equivalents - Money Market Funds [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	7,477	8,911
Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member] \| US Treasury Securities [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Observable Inputs (Level 2) [Member] \| Cash Equivalents - Money Market Funds [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Unobservable Inputs (Level 3) [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Unobservable Inputs (Level 3) [Member] \| US Treasury Securities [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	0	0
Recurring [Member] \| Significant Other Unobservable Inputs (Level 3) [Member] \| Cash Equivalents - Money Market Funds [Member]
Investments held in Trust Account [Abstract]
Investments held in Trust Account	$ 0	$ 0